Traders sold shares of UnitedHealth Group Inc (NYSE:UNH) on strength during trading hours on Wednesday. $127.89 million flowed into the stock on the tick-up and $202.41 million flowed out of the stock on the tick-down, for a money net flow of $74.52 million out of the stock. Of all equities tracked, UnitedHealth Group had the 29th highest net out-flow for the day. UnitedHealth Group traded up $2.14 for the day and closed at $228.78
Several research firms recently weighed in on UNH. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 price target on the stock in a research note on Saturday, January 20th. Argus upped their price target on UnitedHealth Group to $270.00 and gave the stock a “buy” rating in a research note on Thursday, January 18th. Credit Suisse Group upped their price target on UnitedHealth Group from $252.00 to $260.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 17th. Oppenheimer upped their price target on UnitedHealth Group from $260.00 to $240.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 17th. Finally, Cantor Fitzgerald upped their price target on UnitedHealth Group to $280.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 17th. Two research analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the stock. UnitedHealth Group has an average rating of “Buy” and a consensus price target of $243.22.
The firm has a market cap of $221,700.00, a PE ratio of 24.08, a PEG ratio of 1.32 and a beta of 0.70. The company has a current ratio of 0.73, a quick ratio of 0.70 and a debt-to-equity ratio of 0.58.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, beating the consensus estimate of $2.50 by $0.09. The firm had revenue of $52.06 billion for the quarter, compared to analysts’ expectations of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The company’s revenue was up 9.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.11 EPS. equities research analysts expect that UnitedHealth Group Inc will post 12.51 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 20th. Stockholders of record on Friday, March 9th will be issued a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a dividend yield of 1.31%. UnitedHealth Group’s payout ratio is 31.58%.
In other news, Director Kenneth Irwin Shine sold 198 shares of the stock in a transaction on Friday, January 19th. The stock was sold at an average price of $242.55, for a total transaction of $48,024.90. Following the transaction, the director now directly owns 1,790,567 shares of the company’s stock, valued at approximately $434,302,025.85. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Michele J. Hooper sold 10,000 shares of the stock in a transaction on Wednesday, January 31st. The shares were sold at an average price of $237.76, for a total value of $2,377,600.00. Following the transaction, the director now directly owns 37,284 shares in the company, valued at $8,864,643.84. The disclosure for this sale can be found here. Insiders have sold a total of 53,396 shares of company stock worth $12,262,067 over the last three months. Insiders own 0.89% of the company’s stock.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Capital International Investors increased its stake in shares of UnitedHealth Group by 399.3% in the 3rd quarter. Capital International Investors now owns 4,132,602 shares of the healthcare conglomerate’s stock worth $809,370,000 after purchasing an additional 3,304,902 shares in the last quarter. Jennison Associates LLC increased its stake in shares of UnitedHealth Group by 146.0% in the 3rd quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock worth $1,085,396,000 after purchasing an additional 3,289,470 shares in the last quarter. Janus Henderson Group PLC increased its stake in shares of UnitedHealth Group by 1,820.1% in the 2nd quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock worth $442,896,000 after purchasing an additional 2,264,242 shares in the last quarter. Egerton Capital UK LLP purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth $368,905,000. Finally, Vanguard Group Inc. increased its stake in shares of UnitedHealth Group by 2.5% in the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after purchasing an additional 1,588,516 shares in the last quarter. 86.00% of the stock is currently owned by hedge funds and other institutional investors.
WARNING: “Traders Sell UnitedHealth Group (UNH) on Strength (UNH)” was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright legislation. The legal version of this story can be accessed at https://www.dispatchtribunal.com/2018/02/14/traders-sell-unitedhealth-group-unh-on-strength-unh.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.